Your search resulted in multiple matches. Please select a position:

Gencode Genes

ZNF585B (ENST00000532828.7) at chr19:37181579-37210536 - Homo sapiens zinc finger protein 585B (ZNF585B), mRNA. (from RefSeq NM_152279)
ZNF585B (ENST00000591492.5) at chr19:37187080-37210505 - zinc finger protein 585B (from HGNC ZNF585B)
ZNF585B (ENST00000591273.5) at chr19:37189734-37210531 - zinc finger protein 585B (from HGNC ZNF585B)
ZNF585B (ENST00000586320.1) at chr19:37189548-37199008 - zinc finger protein 585B (from HGNC ZNF585B)
ZNF585B (ENST00000534363.1) at chr19:37207195-37218153 - zinc finger protein 585B (from HGNC ZNF585B)
ZNF585B (ENST00000531805.5) at chr19:37184820-37190476 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt E9PQH3)
ZNF585B (ENST00000527838.5) at chr19:37184822-37210484 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt F2Z3L4)
ZNF585B (ENST00000526705.1) at chr19:37190073-37210505 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt E9PQ00)
ZNF585B (ENST00000392156.7) at chr19:37189703-37210549 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt E9PNT4)
AC012309.1 (ENST00000590245.5) at chr19:37156331-37210512 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt E9PNT4)
TP53 (ENST00000269305.8) at chr17:7668402-7687538 - Homo sapiens tumor protein p53 (TP53), transcript variant 2, mRNA. (from RefSeq NM_001126112)
TP53 (ENST00000622645.4) at chr17:7668404-7687481 - Homo sapiens tumor protein p53 (TP53), transcript variant 3, mRNA. (from RefSeq NM_001276696)
TP53 (ENST00000510385.5) at chr17:7668402-7675493 - Homo sapiens tumor protein p53 (TP53), transcript variant 6, mRNA. (from RefSeq NM_001276698)
TP53 (ENST00000455263.6) at chr17:7668404-7687481 - Homo sapiens tumor protein p53 (TP53), transcript variant 4, mRNA. (from RefSeq NM_001276695)
TP53 (ENST00000445888.6) at chr17:7668421-7687487 - Homo sapiens tumor protein p53 (TP53), transcript variant 2, mRNA. (from RefSeq NM_001276761)
TP53 (ENST00000610292.4) at chr17:7668402-7687481 - Homo sapiens tumor protein p53 (TP53), transcript variant 8, mRNA. (from RefSeq NM_001126118)
TP53 (ENST00000617185.4) at chr17:7668402-7687550 - Homo sapiens tumor protein p53 (TP53), transcript variant 3, mRNA. (from RefSeq NM_001126114)
TP53 (ENST00000504937.5) at chr17:7668402-7675493 - Acts as a tumor suppressor in many tumor types; induces  growth arrest or apoptosis depending on the physiological  circumstances and cell type. Involved in cell cycle regulation as  a trans-activator that acts to negatively regulate cell division  by controlling a set of genes required for this process. One of  the activated genes is an inhibitor of cyclin-dependent kinases.  Apoptosis induction seems to be mediated either by stimulation of  BAX and FAS antigen expression, or by repression of Bcl-2  expression. Induces the transcription of long intergenic non-  coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21  participates in TP53-dependent transcriptional repression leading  to apoptosis and seem to have to effect on cell-cycle regulation.  Implicated in Notch signaling cross-over. Prevents CDK7 kinase  activity when associated to CAK complex in response to DNA damage,  thus stopping cell cycle progression. Isoform 2 enhances the  transactivation activity of isoform 1 from some but not all TP53-  inducible promoters. Isoform 4 suppresses transactivation activity  and impairs growth suppression mediated by isoform 1. Isoform 7  inhibits isoform 1-mediated apoptosis. (from UniProt P04637)
TP53 (ENST00000504290.5) at chr17:7668402-7675493 - Acts as a tumor suppressor in many tumor types; induces  growth arrest or apoptosis depending on the physiological  circumstances and cell type. Involved in cell cycle regulation as  a trans-activator that acts to negatively regulate cell division  by controlling a set of genes required for this process. One of  the activated genes is an inhibitor of cyclin-dependent kinases.  Apoptosis induction seems to be mediated either by stimulation of  BAX and FAS antigen expression, or by repression of Bcl-2  expression. Induces the transcription of long intergenic non-  coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21  participates in TP53-dependent transcriptional repression leading  to apoptosis and seem to have to effect on cell-cycle regulation.  Implicated in Notch signaling cross-over. Prevents CDK7 kinase  activity when associated to CAK complex in response to DNA damage,  thus stopping cell cycle progression. Isoform 2 enhances the  transactivation activity of isoform 1 from some but not all TP53-  inducible promoters. Isoform 4 suppresses transactivation activity  and impairs growth suppression mediated by isoform 1. Isoform 7  inhibits isoform 1-mediated apoptosis. (from UniProt P04637)
TP53 (ENST00000420246.6) at chr17:7668404-7687481 - Acts as a tumor suppressor in many tumor types; induces  growth arrest or apoptosis depending on the physiological  circumstances and cell type. Involved in cell cycle regulation as  a trans-activator that acts to negatively regulate cell division  by controlling a set of genes required for this process. One of  the activated genes is an inhibitor of cyclin-dependent kinases.  Apoptosis induction seems to be mediated either by stimulation of  BAX and FAS antigen expression, or by repression of Bcl-2  expression. Induces the transcription of long intergenic non-  coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21  participates in TP53-dependent transcriptional repression leading  to apoptosis and seem to have to effect on cell-cycle regulation.  Implicated in Notch signaling cross-over. Prevents CDK7 kinase  activity when associated to CAK complex in response to DNA damage,  thus stopping cell cycle progression. Isoform 2 enhances the  transactivation activity of isoform 1 from some but not all TP53-  inducible promoters. Isoform 4 suppresses transactivation activity  and impairs growth suppression mediated by isoform 1. Isoform 7  inhibits isoform 1-mediated apoptosis. (from UniProt P04637)
TP53 (ENST00000620739.4) at chr17:7668402-7687538 - Acts as a tumor suppressor in many tumor types; induces  growth arrest or apoptosis depending on the physiological  circumstances and cell type. Involved in cell cycle regulation as  a trans-activator that acts to negatively regulate cell division  by controlling a set of genes required for this process. One of  the activated genes is an inhibitor of cyclin-dependent kinases.  Apoptosis induction seems to be mediated either by stimulation of  BAX and FAS antigen expression, or by repression of Bcl-2  expression. Induces the transcription of long intergenic non-  coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21  participates in TP53-dependent transcriptional repression leading  to apoptosis and seem to have to effect on cell-cycle regulation.  Implicated in Notch signaling cross-over. Prevents CDK7 kinase  activity when associated to CAK complex in response to DNA damage,  thus stopping cell cycle progression. Isoform 2 enhances the  transactivation activity of isoform 1 from some but not all TP53-  inducible promoters. Isoform 4 suppresses transactivation activity  and impairs growth suppression mediated by isoform 1. Isoform 7  inhibits isoform 1-mediated apoptosis. (from UniProt P04637)
TP53 (ENST00000610538.4) at chr17:7668404-7687481 - Acts as a tumor suppressor in many tumor types; induces  growth arrest or apoptosis depending on the physiological  circumstances and cell type. Involved in cell cycle regulation as  a trans-activator that acts to negatively regulate cell division  by controlling a set of genes required for this process. One of  the activated genes is an inhibitor of cyclin-dependent kinases.  Apoptosis induction seems to be mediated either by stimulation of  BAX and FAS antigen expression, or by repression of Bcl-2  expression. Induces the transcription of long intergenic non-  coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21  participates in TP53-dependent transcriptional repression leading  to apoptosis and seem to have to effect on cell-cycle regulation.  Implicated in Notch signaling cross-over. Prevents CDK7 kinase  activity when associated to CAK complex in response to DNA damage,  thus stopping cell cycle progression. Isoform 2 enhances the  transactivation activity of isoform 1 from some but not all TP53-  inducible promoters. Isoform 4 suppresses transactivation activity  and impairs growth suppression mediated by isoform 1. Isoform 7  inhibits isoform 1-mediated apoptosis. (from UniProt P04637)
TP53 (ENST00000619485.4) at chr17:7668421-7687487 - Acts as a tumor suppressor in many tumor types; induces  growth arrest or apoptosis depending on the physiological  circumstances and cell type. Involved in cell cycle regulation as  a trans-activator that acts to negatively regulate cell division  by controlling a set of genes required for this process. One of  the activated genes is an inhibitor of cyclin-dependent kinases.  Apoptosis induction seems to be mediated either by stimulation of  BAX and FAS antigen expression, or by repression of Bcl-2  expression. Induces the transcription of long intergenic non-  coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21  participates in TP53-dependent transcriptional repression leading  to apoptosis and seem to have to effect on cell-cycle regulation.  Implicated in Notch signaling cross-over. Prevents CDK7 kinase  activity when associated to CAK complex in response to DNA damage,  thus stopping cell cycle progression. Isoform 2 enhances the  transactivation activity of isoform 1 from some but not all TP53-  inducible promoters. Isoform 4 suppresses transactivation activity  and impairs growth suppression mediated by isoform 1. Isoform 7  inhibits isoform 1-mediated apoptosis. (from UniProt P04637)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_152279.3 at chr19:37181579-37210549

NCBI RefSeq and Ensembl transcripts from the MANE Project (v0.6)

ZNF585B at chr19:37181579-37210536

RefSeq Genes

ZNF585B at chr19:37181579-37210536 - (NM_152279) zinc finger protein 585B

Non-Human RefSeq Genes

znf585b at chr19:51872907-52156569 - (NM_001045629) zinc finger protein 585B
ZNF585B at chr19:37182230-37210549 - (NM_001270920) zinc finger protein 585B
ZNF585B at chr19:37182230-37210523 - (NM_001132123) zinc finger protein 585B
znf585b.L at chr19:36626774-37363386 - (NM_001087991) zinc finger protein 585B L homeolog
znf585b.S at chr8:144773839-144977414 - (NM_001172134) zinc finger protein 585B S homeolog
znf585b.S at chr19:57547446-58128402 - (NM_001172134) zinc finger protein 585B S homeolog
znf585b.S at chr19:37243038-37803806 - (NM_001172134) zinc finger protein 585B S homeolog

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

ZNF585B at chr19:37181579-37210536
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

ZNF585B at chr19:37181579-37210536
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37189548-37199008

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

ZNF585B at chr19:37181579-37210549
ZNF585B at chr19:37184820-37190476
ZNF585B at chr19:37184822-37210484
ZNF585B at chr19:37187080-37210505
ZNF585B at chr19:37189548-37199008
ZNF585B at chr19:37189703-37210549
ZNF585B at chr19:37189734-37210531
ZNF585B at chr19:37190073-37210505
ZNF585B at chr19:37207195-37218153

BC093625 Alignments in Human Aligned mRNAs

This aligns in multiple positions. Click on a hyperlink to go to tracks display at a particular alignment.
 SIZE IDENTITY CHROMOSOME STRAND  START     END       cDNA   START  END  TOTAL
------------------------------------------------------------------------------
 2468  100.0%         19     -  37185163  37207205  BC093625     1  2468  2468

JU327076 Alignments in Non-Human Aligned mRNAs

This aligns in multiple positions. Click on a hyperlink to go to tracks display at a particular alignment.
 SIZE IDENTITY CHROMOSOME STRAND  START     END       cDNA   START  END  TOTAL
------------------------------------------------------------------------------
 1788   96.1%         19     +-  37184538  37186331  JU327076     1  1794  1794